GlaxoSmithKline PLC (GSK.L) News Headlines

▮ More

Date

Headline

3/4/2021 2:21:01 AM KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent

3/3/2021 9:42:40 AM Stock Alert: Vir Biotechnology Closes Enrollment In COVID-19 Vaccine Trial

2/25/2021 9:44:19 AM GSK : Phase 2 Trial Of Otilimab In Hospitalized COVID-19 Patients Did Not Reach Significance

2/25/2021 8:29:49 AM GSK Announces Otilimab Data For Treatment Of Hospitalised Adult Patients With COVID-19

2/22/2021 6:02:15 AM Sanofi, GSK To Refine Antigen Formulation Of COVID-19 Vaccine Based On Initial Phase 1/2 Study

2/22/2021 5:44:42 AM Sanofi, GSK Begin Phase 2 Study Of Adjuvanted Recombinant Protein-based COVID-19 Vaccine Candidate

2/17/2021 7:45:36 AM GlaxoSmithKline, Vir Expand Collaboration To Include Respiratory Viruses

2/17/2021 7:31:34 AM GlaxoSmithKline And Vir Biotechnology Sign Binding Agreement To Expand Existing Collaboration

2/16/2021 10:02:31 AM GSK Consumer Healthcare Announces Launch Of TUMS Naturals

2/11/2021 7:21:17 AM Novartis' Sandoz To Buy GSK's Cephalosporin Antibiotics Business - Quick Facts

2/11/2021 7:04:59 AM Sandoz Signs Agreement To Acquire GSK's Cephalosporin Antibiotics Business

2/5/2021 8:42:34 AM CureVac, UK To Collaborate On Development Of Vaccines Against SARS-CoV-2 Variants

2/3/2021 7:37:32 AM GlaxoSmithKline FY20 Adj. Operating Profit Up 2% At CER On Turnover Increase Of 3%

2/3/2021 7:09:10 AM GSK FY Total EPS 115.5p, Up 23% AER

2/3/2021 2:47:14 AM GSK, CureVac To Develop MRNA COVID-19 Vaccines

2/3/2021 2:07:02 AM GSK, CureVac Announce New EUR 150 Mln Collaboration To Develop MRNA COVID-19 Vaccines

2/2/2021 2:58:34 AM ADMS Gets FDA Nod, ARQT Soars On Psoriasis Trial Data, DVAX Catches Eye, PRTA On Watch

1/28/2021 2:49:22 AM AGTC Sheds Light On Achromatopsia Trials, LLY, VIR And GSK Team Up, CVM Turns Head As It Awaits Data

1/27/2021 7:03:05 AM Lilly, Vir Biotechnology, GSK Say First Patient Dosed In Expanded BLAZE-4 Trial - Quick Facts

1/27/2021 6:46:51 AM Lilly, Vir Biotechnology And GSK Announce First Patient Dosed In Expanded BLAZE-4 Trial For COVID-19

Glaxosmithkline Plc (GSK.L)